Omnicell

This article has multiple issues. Please help or discuss these issues on the talk page. (Learn how and when to remove these template messages) The topic of this article may not meet Wikipedia's notability guidelines for companies and organizations. Please help to demonstrate the notability of the topic by citing reliable secondary sources that are independent of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be merged, redirected, or deleted. Find sources:  –  ·  ·  · scholar · JSTOR (April 2021) (Learn how and when to remove this template message) This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help by replacing them with more appropriate citations to reliable, independent, third-party sources. (April 2021) (Learn how and when to remove this template message) (Learn how and when to remove this template message)

Omnicell, Inc.

Type	Public
Traded as	Nasdaq: OMCL
Industry	Healthcare technology services
Founded	1992
Founder	Randall A. Lipps
Headquarters	Mountain View, California , United States
Key people	Randall A. Lipps (Chairman, President, Founder, and CEO) Scott Seidelmann (Chief Commercial Officer) Peter Kuipers (Chief Financial Officer) Dan S. Johnston (Chief Legal and Administrative Officer) Christine Mellon (Chief People Officer)
Revenue	US$892.2  million (2020 GAAP[1])
Operating income	US$117.4  million (2020 – Non-GAAP[1])
Net income	US$111.3  million (2020 – Non-GAAP[1])
Total assets	US$1.82  billion (2020[1])
Total equity	US$967.5  million[1]
Number of employees	2900 (2020[1])
Website	https://www.omnicell.com/

Omnicell, Inc. is an American multinational healthcare technology company headquartered in Mountain View, California. It manufactures automated systems for medication management in hospitals and other healthcare settings, and medication adherence packaging and patient engagement software used by retail pharmacies. Its products are sold under the brand names Omnicell and EnlivenHealth.

Company history[]

1992-1999[]

Omnicell Technologies, Inc. was founded in September 1992 by Randall A. Lipps after his daughter was hospitalized at birth and he observed nurses had difficulty locating medical supplies. With the help of graduate students from Stanford University, he developed a prototype of a system that automated inventory management tasks performed manually by nurses.^[2]

With Lipps as the chairman of the company, it commercially began developing automated supply cabinets in 1993. The cabinets were capable of tracking transaction data, inventory levels, expenses, and patient billing. Sales figures reached $7.7 million by the end of 1995 and increased the following year to $21.5 million. The company expanded services by developing pharmacy automation systems for dispensing medications in 1996. They expanded their product line in 1999 by acquiring the SureMed line of pharmacy cabinets from Baxter Healthcare Corp.^[2]

2000-2020[]

By the end of the 1990s, the company had installed more than 14,000 automated dispensing cabinets in more than 1,300 healthcare facilities, and sales grew to $50 million.^[2] Omnicell went public in August 2001, changing the company’s name to Omnicell, Inc.^[3]

In 2002 Lipps assumed the role of CEO, replacing Sheldon D. Asher. In 2003, Omnicell acquired BCX Technology, Inc., a maker of wireless, handheld bar-code scanners that could track pharmaceutical dispensation.^[2] The company further expanded with more acquisitions. Its purchase of MTS Technologies added multiple-dose medication blister cards used by retail pharmacies to encourage medication adherence. The acquisition of Aesynt Inc. added pharmacy robots for inventory management, specialized IV compounding robots to remove human error, and pharmacy data intelligence software. The acquisition of Ateb, Inc., which provided patient engagement and patient communication systems to retail pharmacies, led to the formation of the EnlivenHealth business segment in 2020.^[4][5]

Acquisitions and partnerships[]

• 2012 – MTS Medication Technologies, Inc., a global medication adherence packaging systems provider^[6]
• 2014 – UK-based SurgiChem Limited, a wholly-owned subsidiary of Care Homes (CFG), for £12,000,000 in a cash transaction^[7]
• 2015 – Germany-based Mach4 Pharma Systems, a robotic dispensing systems provider^[8]
• 2015 – Partnered with Avantec for distribution of Omnicell products in UK^[9]
• 2016 – Acquired medication technology company Aesynt Inc. for $275 million, adding central pharmacy dispensing robotics, IV compounding robotics, and pharmacy data analytics to the company’s services^[10]
• 2016 – Acquired Ateb, Inc., together with its Canadian affiliate, Ateb Canada Ltd, providers of pharmacy-based patient care solutions and medication synchronization to independent and chain pharmacies^[5]
• 2017 – InPharmics, a Mississippi-based technology and services company that provides advanced pharmacy informatics solutions to hospital pharmacies^[11]
• 2020 – Acquired the 340B Link business of Pharmaceutical Strategies Group (PSG)^[12]
• 2021 – Partnership with Guy’s and St Thomas’ NHS Foundation Trust, London to develop technology-enabled inventory optimization and intelligence services^[13]

Finances[]

This section does not cite any sources. Please help by adding citations to reliable sources. Unsourced material may be challenged and removed. (April 2021) (Learn how and when to remove this template message)

References[]

External links[]

• Official website